Skip to main content
. Author manuscript; available in PMC: 2019 Nov 7.
Published in final edited form as: Hepatoma Res. 2019 Oct 13;5:38. doi: 10.20517/2394-5079.2019.013

Table 5.

Predictors of 10-year survival after transplant

Univariate odds-ratio (95%CI) Multivariate odds-ratio (95%CI)
Age ≥ 65 2.45 (0.24–25.0)
Sex (Males) 3.0 (0.66–13.3)
Hepatitis B 1.41 (0.49–4.10)
Hepatitis C 0.53 (0.19–1.48)
Alcohol history 0.92 (0.34–2.49)
NASH/NAFLD 0.76 (0.14–4.08)
HCC found with surveillance 0.29 (0.09–0.98) 0.29 (0.07–1.21)
BMI ≥ 25 0.71 (0.22–2.26)
BMI ≥ 30 0.86 (0.27–2.74)
Smoking 1.40 (0.52–3.78)
Diabetes 0.37 (0.12–1.14) 0.51 (0.12–2.20)
Hyperlipidemia 1.04 (0.21–5.09)
Hypertension 0.32 (0.10–0.98) 0.28 (0.06–1.34)
Normal AFP 0.55 (0.20–1.50)
Size ≥ 5 cm 1.62 (0.28–9.58)
Single tumor 1.13 (0.33–3.84)
Recurrence 0.29 (0.09–0.98) 0.19 (0.03–1.02)

Significant values are in bold. NASH: non-alcoholic steatohepatitis; NAFLD: non-alcoholic fatty liver disease; HCC: hepatocellular cancer; BMI: body mass index; AFP: alpha feto protein